Your browser doesn't support javascript.
Early vs Delayed Surgery for Esophageal Cancer During the COVID-19 Pandemic.
Bajaj, Simar S; Shah, Kavya M; Potter, Alexandra L; Mayne, Nicholas R; Sachdeva, Uma M; Lin, Mong-Wei; Yang, Chi-Fu Jeffrey.
  • Bajaj SS; From the Department of Thoracic Surgery, Massachusetts General Hospital, Boston, MA (Bajaj, Shah, Potter, Sachdeva, Yang).
  • Shah KM; From the Department of Thoracic Surgery, Massachusetts General Hospital, Boston, MA (Bajaj, Shah, Potter, Sachdeva, Yang).
  • Potter AL; From the Department of Thoracic Surgery, Massachusetts General Hospital, Boston, MA (Bajaj, Shah, Potter, Sachdeva, Yang).
  • Mayne NR; the Department of Medicine, Duke University, Durham, NC (Mayne).
  • Sachdeva UM; From the Department of Thoracic Surgery, Massachusetts General Hospital, Boston, MA (Bajaj, Shah, Potter, Sachdeva, Yang).
  • Lin MW; the Department of Thoracic Surgery, National Taiwan University, Taipei, Taiwan (Lin).
  • Yang CJ; From the Department of Thoracic Surgery, Massachusetts General Hospital, Boston, MA (Bajaj, Shah, Potter, Sachdeva, Yang).
J Am Coll Surg ; 235(2): 174-184, 2022 08 01.
Article in English | MEDLINE | ID: covidwho-2001543
ABSTRACT

BACKGROUND:

During the coronavirus disease 2019 pandemic, national guidelines recommended that elective surgery for esophageal cancer be deferred by 3 months when hospital resources are limited. The impact of this delay on patient outcomes is unknown. We sought to evaluate the survival of patients with stage I and II/III esophageal cancer who undergo early vs delayed treatment. STUDY

DESIGN:

Using the National Cancer Database from 2010 to 2017, multivariable Cox proportional hazards modeling and propensity score-matched analysis were employed to compare survival of patients with stage I esophageal cancer who received early (0 to 4 weeks after diagnosis) vs delayed esophagectomy (12 to 16 weeks) and of patients with stage II/III esophageal cancer who-after receiving timely chemoradiation (0 to 4 weeks after diagnosis)-underwent early (9 to 17 weeks) vs delayed esophagectomy (21 to 29 weeks).

RESULTS:

For stage I esophageal cancer, 226 (41.7%) patients underwent early esophagectomy, and 316 (58.3%) patients underwent delayed esophagectomy. Propensity score matching created 2 groups of 134 patients with early or delayed esophagectomy, whose 5-year survival was comparable (hazard ratio [HR] 65.0% [95% confidence interval (CI) 55.2% to 73.2%] vs HR 65.1% [95% CI 55.6% to 73.1%], p = 0.50). For stage II/III esophageal cancer, 1,236 (86.1%) patients underwent early esophagectomy, and 200 (13.9%) underwent delayed esophagectomy. Propensity score matching created 2 groups of 130 patients; the early esophagectomy group had improved 5-year survival compared with the delayed esophagectomy group (HR 41.6% [95% CI 32.1% to 50.8%] vs HR 22.9% [95% CI 14.9% to 31.8%], p = 0.006).

CONCLUSIONS:

Early esophagectomy was associated with similar survival compared with delayed esophagectomy for patients with stage I esophageal cancer. For patients with stage II/III esophageal cancer, early esophagectomy was associated with improved survival relative to delayed esophagectomy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Esophageal Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Am Coll Surg Journal subject: Gynecology / Obstetrics Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Esophageal Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Am Coll Surg Journal subject: Gynecology / Obstetrics Year: 2022 Document Type: Article